SNCA and Parkinson disease: As regards to PD, the protective potential of thalidomide was first reported in MPTP-intoxicated mice [57], and both thalidomide and lenalidomide were subsequently evaluated in α-synuclein overexpressing mice, providing an improvement in both motor performance and neuropathological parameters [17].